The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $683,442 Project Grant on September 1, 2023 to The Trustees of the University of Pennsylvania to conduct a 3-year study on "Trajectories of Neuroimaging and Blood-Based Biomarkers After Remote Traumatic Brain Injury and Associations with Dementia Risk." The University of Pennsylvania will collaborate with Mayo Clinic on a sub-award to investigate longitudinal changes in brain...
This $1,199,997.00 Project Grant award from the Defense Health Agency, under the Department of Defense's Military Medical Research and Development program (CFDA 12.420), is funding research to prevent trauma-related infections during prolonged care. The grant was awarded on Sep 30, 2023 to The Trustees Of The University Of Pennsylvania - doing business as Clinical Practices Of The University Of Pennsylvania, a private university and non-profit research institution. The research aims to develop...
This $569,851 federal Project Grant award was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research at the University of Pittsburgh to assess the effectiveness of a whole blood test for improving the assessment and triage of patients with mild traumatic brain injury presenting to civilian emergency departments. The research aims to transform healthcare for military service members and the broader public by...
The Trustees of the University of Pennsylvania were awarded a $299,099 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research into Metabolic Target Identification in Age-Associated B Cells from May 1, 2023 through April 30, 2025. As part of the Military Medical Research and Development program's goals of transforming military and public health care through innovative medical research, this...
The U.S. Department of the Army Medical Command awarded a $2,027,311 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The research will explore innovative approaches to...
This federal Project Grant award of $2,699,157.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research on the effectiveness of a traumatic brain injury whole blood test in improving assessment and triage for patients with mild traumatic brain injury presenting to civilian emergency departments. The grant was awarded to the University of Pittsburgh on July 1, 2025, with a final completion date of June 30, 2029. The research...
The U.S. Defense Health Agency awarded a $831,658 Project Grant to Pennsylvania State University, doing business as Penn State Milton S. Hershey Medical Center, under the Military Medical Research and Development program (CFDA 12.420). The funding will support a 3-year research project investigating "GUT-BRAIN MECHANISMS OF IMPROVING HEALTH IN AN ANIMAL MODEL OF SCI FOLLOWING WEIGHT LOSS SURGERY". As a leading academic medical center, Penn State has a track record of delivering...
This federal Project Grant award of $1,999,996 was provided by the Defense Health Agency to Temple University to conduct research on "IDENTIFYING DIAGNOSTIC BIOMARKERS OF THE CEREBROVASCULAR CONTRIBUTIONS TO COGNITIVE IMPAIRMENT IN REPEATED BLAST CONCUSSION". The award is funded through the Military Medical Research and Development (CFDA 12.420) program, which supports advanced biomedical research to transform healthcare for military service members and the broader public. The key...
The University of Pennsylvania's Clinical Practices is the recipient of a $861,250 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 30, 2024, supports the advancement of mechanistic understanding of autoimmunity in aplastic anemia through HLA allele specificity research. The project aims to provide critical insights that could lead to improved treatments for this medical condition, with a...
This Project Grant award of $1,625,000 from the U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports in-vivo mechanistic characterization of the angiogenic immune checkpoint in liver cancer at the Trustees of the University of Pennsylvania. The research aims to advance scientific understanding and develop solutions for this important health challenge. The award commenced on September 1, 2023 and is scheduled for completion by August 31, 2027. As a...